NPPA issued a notification regarding the fixation of the retail price of Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg + Metformin Hydrochloride IP 1000 mg

Feb 02, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on January 31, 2024, issued a notification regarding the fixation of the retail price of Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg + Metformin Hydrochloride IP 1000 mg.

The following has been stated: -

•Composition: Each film-coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg + Metformin Hydrochloride IP 1000 mg for M/s Skymap Pharmaceuticals Pvt Ltd (Manufacturer) and M/ German Remedies Pharmaceuticals Pvt Ltd (Marketer) the Retail Price (without local taxes) is 10.39.

The detailed notification is given in the document attached below.

[Notification No.19(3758)/2023/DP/NPPA/Div.III/7359/2024]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT